The following NSCLC therapy related genes were chosen: ERCC1, MET, HER3, JAG1 and VIM. Raw data (Cq-values) from patient samples are provided in the supplementary data section (Supplementary Table 5). This evidence concerns the gene MET and non-small cell lung carcinoma.